The beryllium lymphocyte proliferation test (BeLPT), has become the principal clinical test for detecting beryllium sensitization and chronic beryllium disease. Uninterpretable BeLPT results can occur in a small but significant proportion of tests from poor lymphocyte growth (PG) or over proliferation of lymphocytes (OP).
has proven to be the most reliable, non-invasive method for identifying BeS. 4 There are a number of intricacies involved with the interpretation of the BeLPT test results. [5] [6] [7] [8] antigens to which all lymphocytes should respond), increased cell death due to problems with blood transport or cell culture conditions, or due to other technical and equipment-related problems that can produce unacceptably high coefficients of variation. As a result of these factors, though the occurrence is infrequent, further refinement of the conditions affecting the BeLPT is warranted.
Although unproven, it is plausible that individual variation in lymphocyte function may produce uninterpretable BeLPT results.
Underlying health conditions, such as hematopoietic malignancies, autoimmune disorders, and immunomodulatory medications, such as corticosteroids, may cause lymphocytes to either over-respond or under-respond in vitro.
We sought to investigate two of the primary reasons that a BeLPT is uninterpretable, which included poor lymphocyte growth (PG) and over-proliferation (OP) of lymphocytes in the control wells during the BeLPT. Specifically, we sought to investigate BeLPT classification of uninterpretable results and their association with participant specific factors. Cell growth is known to be affected by the specific serum lot used in the culture medium, with some lots supporting more or less robust proliferation in response to antigens and mitogens. 8 In addition, procedural differences in the BeLPT can occur across laboratories and are important factors to control for when the goal is to assess whether there are any participant specific risk factors associated with an uninterpretable test result.
Under newly accepted rules by the Occupational Safety and
Health Administration (OSHA), beryllium screening will increase and the BeLPT will be used as the standard screening method. Current workers meeting the criteria set forth in OSHA's occupational exposure to beryllium rule will be required to have a BeLPT as part of medical surveillance and follow up BeLPTs every 2 years. 
| Definition of PG and OP
In vitro lymphocyte growth requires the addition of pooled human ABpositive serum to the growth medium (RPMI 1640) during the incubation period of the BeLPT. 3 Since cell growth is affected by the specific serum lot the threshold at which cultures experience OP is specific to a given pooled serum lot and has been routinely defined as follows. The OP serum specific cut-point is created by performing
BeLPTs on roughly 30 blood samples from individuals who have no prior history of beryllium exposure. The OP cut-points are defined as the 99.9 percentile of the cell growth in control samples, that is, cells that have been incubated in growth media in the absence of beryllium salts. Alternatively, the PG cut-points are defined as twice the background noise (ie, counts with growth media alone). However, these definitions are not shared across laboratories and the information needed to apply these methods to the entire BeLPT dataset was not available. Thus, for purposes of this study, the OP and PG cutpoints were redefined as follows in order to harmonize the data across the laboratories.
Eleven different pooled serum lots were used to run the BeLPTs for the NSSP over the 10-year study period. BeLPT interpretation occurs at two different time points for cells in culture. However, these interpretation times were not the same in both labs. One lab interprets the BeLPTs after 4 and 6 days of incubation and the other after 5 and 7 days. Thus, OP thresholds were defined for two separate interpretation times for a given serum lot. In order to determine the OP threshold, we identified individuals who only ever had a normal BeLPT test result, referred to from here on as "exposed normals." For individuals with multiple BeLPTs, their first test result was chosen. Cell counts from the control wells were obtained for this group of exposed normal individuals. These test results were then stratified by serum lot, and for a given serum and interpretation time (eg, Day 4), an OP threshold was defined as follows. First, for a given serum lot and interpretation time, 25% of the population of exposed normal individuals was randomly sampled. A sensitivity analysis was used to identify the percentage of exposed normal individuals to be randomly sampled that yielded a representative sample, yet did not oversample the population. An OP threshold was defined for a given serum and interpretation time by obtaining the 99.9 percentile of the cell counts from the random sample of exposed normal individuals.
This process was repeated for each serum and interpretation time.
Unlike OP, a fixed value of less than or equal to 85 counts per minute (CPM) of cells in control wells was defined as the PG cut-point. This value was determined by clinical and laboratory subject matter experts.
| Case-control selection
BeLPT test results were excluded from the case-control selection if the BeLPT result was abnormal (n = 617), borderline (n = 416), or invalid due to reasons not related to lymphocyte growth (n = 726). The main reasons for invalid tests were attributed to cell death prior to culture or the quantity of the blood sample not being sufficient to run the BeLPT. 
| Measures
All participants' clinical variables obtained from the NSSP questionnaire and medical examination data that had enough data (n = 174)
were investigated as potential predictors of the BeLPT outcomes. The NSSP does not collect information on all variables for each participant.
Thus, variables that had less than 20 responses for a given outcome (ie, PG or OP) were excluded from the analysis due to a lack of data to make a meaningful assessment. In order to assess the association of the different NSSP variables with the outcome of interest (ie, PG or OP), two different approaches were taken. First, we relied on subject matter experts to identify biologically important variables. Yet, due to the gap in our understanding about what risk factors may be associated with PG and OP, we also used a univariate approach to identify potential candidate variables that were highly associated with a given outcome. This was an attempt to reduce the risk that we overlooked important variables. The two approaches are described in detail below.
| Statistical analyses-Association
Both the subject matter expert approach and the univariate association approach employed a multivariable generalized linear mixed model with a binary link function. This enabled us to model the relationship between the outcome of interest and the selected covariates, while accounting for the correlation between tests that were performed using the same serum lot. The proportion of the total variance in the outcome that can be attributed to serum lot was assessed using the intraclass correlation coefficient (ICC). In addition, since the NSSP dataset is primarily composed of older males, all models were adjusted for gender and age. Age was treated as a categorical variable and separated into four categories; <55, 55-64, 65-74, and 75 years and over. Lastly, it was necessary to control for the lab where the test was performed in all models by including it as a covariate. This was done on the basis that test performance can vary across labs and was necessary to account for when assessing the association between uninterpretable BeLPTs and participant characteristics.
Mixed models were run using PROC NLMIXED in SAS version 9.4
and glmer from the lme4 package in R version 3.2.4. The first approach selected candidate variables for the multivariable model that were chosen by subject matter experts (five in total).
Subject matter experts were asked to rank the candidate variables on a scale of 0-5 (five representing the strongest relationship) for how related they expect them to be with each outcome. A given variable was then ranked based on its combined score (maximum score of 25).
Candidate variables were identified as variables with a combined score greater than 10 and included in the multivariable model. Collinearity was assessed by the variance inflation factor (VIF) and any variables with a VIF greater than 5 were investigated further. In the event variables were collinear, the one with the lower ranking was dropped.
Interrater reliability was assessed using Krippendorff's Alpha, where an alpha value of 1 indicates perfect agreement and a value of 0 indicates agreement that is no better than chance. 21 The second approach selected candidate variables by assessing their association with a given outcome in the univariate setting.
Variables found to have a P-value less than 0.05 were considered as candidate variables for the multivariable model. Collinearity issues were assessed using the criteria previously discussed. However, in the event variables were collinear, variables with a weaker association in the univariate setting were removed in favor of keeping those with a stronger association.
In order to achieve a parsimonious model, variable reduction for the multivariable model was conducted using an all-subsets approach, implemented using the glmulti package in R. 22 Essentially, for each approach described above all possible model subsets of the candidate variables were modeled and ranked using the corrected Akaike's information criterion (AICc). The model with the lowest AICc out of the two approaches was chosen and interpreted for a given outcome.
Odds ratios (OR) from the resulting model were used to assess the association between the outcome and individual predictors. In order to account for multiple testing in the multivariable models, the false discovery rate (FDR) and corresponding adjusted P-values were computed (FDR maintained at 5%) based on the number of covariates assessed in the model. 23 Accordingly, significance of the model results
was assessed based on the results of the FDR adjusted P-values.
| Statistical analyses-Classification
The NSSP dataset provided us with the unique opportunity to explore alternative approaches when attempting to use participant specific factors to predict an uninterpretable BeLPT result. Due to the size of the NSSP dataset, in addition to using a multivariable generalized linear mixed model approach, we also explored the use of the machine learning technique called classification and regression tree (CART).
This also provided us with a means to validate whether the conclusions were similar among the different methods. The dataset was split into a training set (2/3) and test set (1/3) and missing data were imputed using a single K Nearest Neighbors (KNN) approach (K = 10)
implemented using the DMwR R package. 24, 25 It is often vital to estimate the uncertainty in imputed data using multiple imputation when the objective is estimation, yet this is not a necessity when the objective is prediction. 26 Variables with a large amount of missingness (ie, over 1000 missing records) were not imputed and were instead excluded from the classification analysis.
Whether an individual could be classified as PG and OP was evaluated using both classification and regression tree (CART) and multivariable generalized linear mixed model approaches. These two approaches were explored since the multivariable generalized linear mixed model framework is limited by multicollinearity, the number of predictors that can be included without overfitting the model, and the inclusion of variables with little to no variation (near 0-variance). The CART framework is much less susceptible to these issues. 27 A CART can be constructed using a number of techniques. We chose to explore two of these, recursive partitioning for classification (RPART) and the cost C5.0 algorithm where boosting was used to combine the ensemble of classification trees to make predictions.
Boosting was implemented using the AdaBoost algorithm for RPART and C5.0 boosting for the C5.0 algorithm. 27 The boosted classification trees were run using the caret package in R version 3.2.4. 28 These algorithms are discussed in detail in the book Applied Predictive
Modeling. 27 Models were ranked/evaluated using partial area under the receiver operating characteristic curve (AUC), where specificities were only assessed in the interval where sensitivities ranged from 0.5 to 1.0.
The partial AUC was used over the complete AUC since we were interested in evaluating different models that had high sensitivity. In the case of screening for PG and OP, an individual will receive the SMITH ET AL.
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BeLPT regardless of their predicted result. Thus, a false positive (ie, incorrectly predicting one as having a PG or OP test result when in fact their BeLPT came back normal) does not result in any unnecessary
testing. Yet, a false negative (ie, incorrectly predicting one as having a normal test result when in fact their BeLPT came back either PG or OP)
provides no insight into why the BeLPT was uninterpretable.
Therefore, allowing for a higher false positive rate enables us to capture more true positives while having no adverse consequences on patients. Finally, the partial AUC values were rescaled to yield the typical interpretation of complete AUC values between 0 and 1 using the pROC package in R version 1.10.0. 29, 30 In order to account for correlation across BeLPTs that were run using the same serum lot, a random intercept was included in the multivariable mixed model. Yet, when using CART to assess OP and PG it was not possible to account for correlation within serum lot in this The CART models were trained over a number of tuning parameters using the training dataset and bootstrapping with 50
replicates. AdaBoost models were tuned using two different versions of the algorithm (M1 and Real) and up to 150 boosting iterations. 31 The boosted C5.0 models were tuned using up to 100 boosting iterations, whether the splits were tree or rule-based, and whether or not winnowing (ie, removal of unimportant predictors) should be applied. 26 For a given algorithm (AdaBoost or C5.0), the training model with the highest partial AUC was selected as the final model and its prediction was evaluated using the test dataset. For each final model the mean partial AUC and 95% confidence interval (z-based) was estimated using the test dataset and bootstrapping with 1000 replicates. Variable importance for the final CART models was assessed by determining the percentage of all tree splits that was associated with a given variable in the test dataset.
The multivariable generalized linear mixed model employed the same all-subsets approach that was used to assess the association of participant characteristics with PG and OP. The differences were that the partial AUC was used to rank models over the AICc and that the allsubsets approach was performed on the imputed dataset so that the datasets used in the classification analyses were identical.
Lastly, logistic regression may underestimate the probability of rare events. 32 Since our outcomes were just under 2%, we assessed whether predictions improved as the frequency of the outcomes increased. This was accomplished using Synthetic Minority Oversampling Technique (SMOTE), which uses a combination of undersampling the majority class (normal test results) and over-sampling the minority class (PG or OP) approaches to simulate new datasets that have a greater frequency of events from the minority class. 33 Using SMOTE, implemented using the DMwR package in R, the number of cases were doubled (over-sampling) with various combinations of under-sampling to create three simulated datasets where the frequency of the cases was increased from roughly 2% to 10%, 20%, and 30%. 25 Simulated datasets were assessed using the same classification approaches detailed above that were used on the full unsimulated dataset. 
| RESULTS

As
| Association for PG
An overview of the final cohort used in the multivariable model to test the association between PG and participant specific factors can be found in Table 1 . Particular serum lots and labs were found to contain a large number of the PG results, further emphasizing the need to control for these variables when assessing participant specific risk factors (Table I) Table 2 .
The variables included in the multivariable model displayed a high association with PG in the univariate setting (differences between the groups are shown in Table 1 
| Association for OP
An overview of the final cohort used in the multivariable model to test the association between OP and participant specific factors can be found in Table 3 . Again, particular serum lots and labs were found to contain a large number of the OP results, further emphasizing the need to control for these variables when assessing participant specific risk factors (Table 3) . The model using the variables selected by the univariate approach was found to have the lowest AICc (1610.80) compared to the model using variables selected by subject matter experts (AICc: 1622.2). Ten variables were included in the all-subsets selection process for the univariate approach since they were shown to have a strong association with OP in the univariate setting. Five of these variables were retained in the final model. The multivariable model results can be found in Table 4 . Similar to what was seen in PG, the variables included in the multivariable model displayed a high association with OP in the univariate setting (differences between the groups are shown in Table 3 ), yet when included together in the multivariable model no significant associations were found. In addition, akin to PG, we observed that a considerable portion of the variation in OP was attributed to serum lot, with an ICC of 0.16.
| Classification
A total of 167 different variables from the NSSP medial screenings were assessed using the CART analysis. The entire cohort of individuals was utilized for the classification analyses since missing data values were imputed using KNN. Thus, the cohort used to assess There were 103 cases in the training set and 51 in the test set for PG, and 105 cases in the training set and 75 in the test set for OP.
| Classification of PG
The majority of the top models from the multivariable generalized linear mixed model using the univariate and all-subsets approach failed to converge. In contrast, the subject matter experts and all-subsets approach did not experience the same convergence issues. However, The performance across the three methods (measured by the partial AUC) was similar but slightly worse than PG, examples of the resulting ROC curves are not shown here for brevity. The partial AUCs resulting from the final models applied to the test dataset are shown in Table 5 . Again, variable importance was low, and across all levels of oversampling, the number of splits associated with a given variable for AdaBoost ranged from 0.0 to 1.8% and 0.0 to 6.0% for C5.0.
| DISCUSSION
Uninterpretable BeLPTs are an infrequent, but potentially costly, occurrence in large scale beryllium disease surveillance programs. If Sample sizes for the model can be found in the participant characteristics overview for Poor Growth in Table 1 . *indicates significance after accounting for multiple testing using the FDR uninterpretable tests can be avoided, it may reduce patient anxiety that may result from uncertainty, as well as save costs associated with repeat venipuncture, shipping, and laboratory analysis. To our knowledge, this is the first study to investigate clinical sources related to BeLPT uninterpretable outcomes. We observed that 3.1% of all
BeLPT results from two labs over a 10-year period were uninterpretable due to PG or OP. The particular pooled AB-positive serum lot used in the assay stood out as the major factor involved in PG and OP.
Additionally, our data show that participant specific factors are not the primary drivers of PG or OP, although several clinical factors for PG, namely hemoglobin concentration, MCHC, and self-reported joint pain, suggest hypotheses for future study. We observed no relationship between other participant specific factors in the multivariable models, for which data were available. Importantly, we did not see evidence of a relationship between clinical risk factors that one might expect to affect this immunoassay, such as cancer and diseases associated with immunosuppression. In addition, there was poor agreement among subject matter experts when they independently and blindly ranked clinical variables that might cause PG and OP. This poor agreement among raters is in line with the notion that potential clinical drivers of uninterpretable results are not well understood.
| Role of laboratory testing conditions in producing uninterpretable results
BeLPT testing laboratories currently evaluate how the human ABpositive pooled serum that is routinely added to cell culture media impacts lymphocyte proliferation in response to beryllium salts, antigens, and mitogens. Our findings suggest that laboratories should also consider how serum lot variability impacts the occurrence of uninterpretable tests when choosing lots.
Serum lot was found to be important in explaining both PG and OP, accounting for 21% and 16% of the variation, respectively. There was a disproportionate number of uninterpretable results related to a specific serum lots and laboratories (Table 1 and 3) . This, coupled with the lack of evidence that participant specific risk factors are driving uninterpretable results, warrants future investigations to examine serum lots and laboratory practices in greater detail. Additionally, we observed that OP thresholds were highly variable across the different serum lots, further reinforcing the importance of serum lot evaluation when assessing lymphocyte proliferation assay performance.
Future studies should examine if adjustment of lymphocyte number in the assay could help optimize the BeLPT. Like all lymphocyte proliferation assays, the BeLPT is dependent on the addition of the patient's white blood cells, including lymphocytes, to the culture medium. Our multivariable analyses showed that lymphocyte count was associated with OP, although it was not significant after accounting for multiple testing. Because the lymphocyte counts in categories other than normal were infrequent, inference on the odds ratios is limited. The classification results showed that the generalized linear mixed model, as well as the CART models, were limited in their ability to distinguish between cases and controls regardless of the amount of oversampling. controlled for differences in laboratory in our initial analysis, we did not interpret its effect. Upon review this has been noted as an area of interest, in order to identify whether there were any significant differences between laboratories after accounting for the differences in serum lot. Therefore, a post hoc analysis that did not control for the FDR was preformed to assess the effect that laboratory had on uninterpret- These results suggest that for PG there seem to be differences between the laboratories beyond serum lot that result in increased odds for PG, but not for OP. We are only able to speculate on why differences may exist, but one possible explanation is that there is no standard definition for PG across laboratories. Even though we took great care to standardize the definition based on subject matter expert guidance, it is possible that a test that would have been labeled as PG at one laboratory might be identified differently if it was processed at different laboratory. This would ultimately lead to differences in how a test was entered into the NSSP database and it is possible that they met our exclusion criteria as a result. For example, if a test was entered as a type of invalid test that met out exclusion criteria, that the data was simply never No results were significant after adjusting P-values using the FDR to account for multiple testing.
Sample sizes for the model can be found in the participant characteristics overview for Over Proliferation in Table 3 . Future insight could be gained by collecting and assessing data on test/laboratory conditions, such as age of serum, sample collection information, and shipping conditions.
| Role of clinical characteristics in producing uninterpretable results
Numerous variables displayed a strong association with uninterpretable results in the univariate analysis, however many of these associations did not persist in the multivariable setting models. Differences in the proportion of uninterpretable results related to a given laboratory and Cancer treatment can also result in reduced lymphocyte growth. 37 Yet, the numerous individual cancer-related variables in the NSSP dataset (eg, histories of cancer in the lung, colon, breast, stomach, and skin) did not show a strong enough association with PG to be included in the final multivariable model. In addition, some of these cancer variables were not explored due to the low prevalence in the study population. A composite cancer variable indicating if one had ever had lung, colon, breast, stomach, and/or skin was created to try to evaluate cancer more holistically, but was not a strong enough univariate factor to enter the final multivariable model. Additionally, diabetes mellitus may impair lymphocyte function. 38 However, blood glucose levels and history of diabetes did not display a strong enough association with PG in the univariate setting to be included in the final multivariable model.
It has been hypothesized that age may also influence lymphocyte growth. For example, older women have shown significantly lower lymphocyte proliferation compared to younger women. 39 While, the percentage of those with PG increased by age group and is consistent with these findings, we observed no significant relationship between PG and age. Similarly, we did not find a significant relationship between gender and PG. However because our cohort tended to be older and predominately male compared to the U.S. population (2010 Census), generalizability to the general population is limited.
An important limitation is that many of the clinical variables are selfreported and subject to recall bias. In addition, the rare event nature of both the outcomes (ie, PG and OP) as well the rare occurrence of many of the health conditions in the dataset (eg, cancer, CBD, rheumatoid arthritis, etc.) limited our assessment of some potentially important clinical risk factors. Missing records were present for numerous individuals, which is believed to be attributed to the algorithms used by the NSSP to select clinical tests based on an individual's past occupational exposures. Thus, we assumed that these records were missing at random and did not attempt to impute these values when evaluating their association with the outcomes. As a result the cohort used in the multivariable models when assessing the association was smaller (PG n = 115, OP n = 165), since individuals were excluded if they did not have complete records for the variables of interest (Table 1 and 3). Lastly, when evaluating the association between patient characteristics and the outcomes, we attempted to assess and select the set of variables that explained the most amount of variation in the outcome of
interest. Yet, we were not able to evaluate all possible combinations and their interactions. There may have been other personal health conditions and certain medications that could have contributed to PG or OP that we were unable to study in the available dataset. For example, some personal health conditions that have been shown to influence lymphocyte growth include exercise, performance enhancing drugs, vitamins, and the human rhinovirus. [40] [41] [42] [43] [44] [45] Nonetheless, the NSSP dataset is one of the most comprehensive collections of lymphocyte proliferation assay data coupled with medical examination data. As such, it currently provides the best grounds on which to evaluate the association between participant specific factors and uninterpretable BeLPTs due to PG and OP.
| CONCLUSIONS
Uninterpretable BeLPTs due to PG and OP were found to be related to the selection of serum lot for the assay and were not shown to be driven by participant specific factors. There was evidence that PG may be influenced by hemoglobin and/or iron. Continued insight into uninterpretable BeLPTs would benefit from a standardization of practices and definitions across laboratories. The role of hemoglobin and lymphocyte count merit consideration when attempting to drive 
